D.E. Shaw & Co’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,178,604
Closed -$40.5M 4336
2014
Q4
$40.5M Buy
1,178,604
+1,074,309
+1,030% +$35M 0.05% 428
2014
Q3
$3.11M Sell
104,295
-38,640
-27% -$819K ﹤0.01% 1895
2014
Q2
$2.87M Sell
142,935
-41,238
-22% -$946K ﹤0.01% 2026
2014
Q1
$5M Sell
184,173
-339,360
-65% -$9.01M 0.01% 1581
2013
Q4
$10.9M Sell
523,533
-561,467
-52% -$10.6M 0.01% 1083
2013
Q3
$19.8M Buy
1,085,000
+377,867
+53% +$6.83M 0.03% 591
2013
Q2
$11.8M Buy
+707,133
New +$11.3M 0.02% 785

Other funds holding AUXL

D.E. Shaw & Co's AUXL Position: Q1 2015 in Review

D.E. Shaw & Co sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,178,604 shares — an estimated $40.5M sold.

D.E. Shaw & Co first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $40.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • D.E. Shaw & Co reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,178,604 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $40.5M.
  • D.E. Shaw & Co first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • D.E. Shaw & Co's AUXILIUM PHARAMCEUTICALS INC position peaked at $40.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.